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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A319Conclusions: The results of this study suggest that HDMPs might be a
common feature in ageing and degenerating weight bearing joints. The
existence of these structures provides novel insights into the mecha-
nism of joint destruction, highlighting the central role of micro-
anatomical changes to the subchondral plate. HDMPs provide a novel
imaging biomarker of joint destruction for diagnosis of joint disease and
to monitor disease progression.
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CHANGES IN EPIPHYSEAL BONE, SUBCHONDRAL BONE PLATE AND
EPIPHYSEAL TRABECULAR BONE IN SURGICALLY AND CHEMICALLY
INDUCED RAT MODELS OF OSTEOARTHRITIS
J. Morko, Z. Peng, J. V€a€ar€aniemi, K.M. Fagerlund, J.P. Rissanen,
J. Bernoulli, J.M. Halleen. Pharmatest Services Ltd, Turku, Finland
Purpose: Several experimental animal models have been developed for
human osteoarthritis (OA) and used to study the preclinical efﬁcacy of
disease and symptom modifying OA drug candidates. The preclinical
efﬁcacy has been determined by various microscopic scoring systems
and joint pain assessments. The histopathology initiative of Osteo-
arthritis Research Society International (OARSI) has presented recom-
mendations for OA assessment in order to standardize preclinical
efﬁcacy studies. Recommendations for rat samples include the histo-
logical analysis of cartilage degeneration and extracellular matrix (ECM)
loss, osteophytes, calciﬁed cartilage and subchondral bone, synovium,
joint capsule, and growth plate. As subchondral bone has been identi-
ﬁed to play an important role in the development and progression of
OA, treatment effects on bone tissue have been studied even in more
detailed. In this study, we performed a systemic characterization of
epiphyseal bone, subchondral bone plate and epiphyseal trabecular
bone together with the assessment of knee joint discomfort and pain
and degenerative changes in articular cartilage and synovium in four rat
OA models.
Methods: The study was conducted using male Lewis rats (body weight
range 330-380 g). Unilateral OA was induced in their knee joints by
applying the following models: 1) intra-articular injection of mono-
iodoacetate (MIA) at the dose of 1 mg, 2) medial meniscal tear (MMT)
combined with medial collateral ligament transection (MCLT), 3)
anterior cruciate ligament transection (ACLT) combined with partial
medial meniscectomy (pMMx), 4) ACLT. Body weight and OA symptoms
were followed in each model during the study. Knee joint discomfort
and pain were used as the symptoms of OA. Knee joint discomfort was
analyzed as static weight bearing using Incapacitance Tester and knee
joint pain as static mechanical allodynia using von Frey monoﬁlaments.
Knee joints were harvested at two different time points in each model
as follows: in the MIA model at 2 and 4 weeks, in the MMT þ MCLT
model at 3 and 6 weeks, in the ACLT þ pMMx model at 4 and 8 weeks,
and in the ACLT model at 5 and 10 weeks. The structure of epiphyseal
bone, subchondral bone plate and epiphyseal trabecular bone were
analyzed in coronal sections of medial tibial plateau followed by the
histological OA assessment as recommended by the OARSI histo-
pathology initiative. This experimental protocol was approved by
National Animal Experiment Board, Regional State Administrative
Agency for Southern Finland, H€ameenlinna, Finland.
Results: Knee joint discomfort was observed in operated hind limbs as
decreased static weight bearing during the ﬁrst week of the study. Knee
joint pain was identiﬁed in operated and MIA-injected hind limbs as
decreased paw withdrawal threshold during the ﬁrst week and at the
end of in-life phase of each model. In the rat MIA model, this knee joint
pain was associated with mild synovial inﬂammation at 2 weeks, car-
tilage degeneration and ECM loss in superﬁcial layer at 2 weeks and
exacerbating down to intermediate layer at 4 weeks, and with the
reduction in the amount of epiphyseal and subchondral bone. In the rat
MMT þ MCLT model, the knee joint pain was observed together with
synovial inﬂammation, cartilage degeneration and the loss of ECM from
superﬁcial layer down to tidemark at 3 and 6 weeks, large osteophytes,
and with the increased amount of epiphyseal and subchondral bone. In
the rat ACLT þ pMMx model, the pain of knee joint was identiﬁed in
association with synovial inﬂammation, cartilage degeneration and
ECM loss from superﬁcial layer down to tidemark at 4 and 8 weeks, and
with large osteophytes. In the rat ACLT model, the knee joint pain was
associated with mild synovial inﬂammation, cartilage degeneration and
the loss of ECM in superﬁcial layer at 5 weeks and exacerbating down to
deep layer at 10 weeks, osteophytes, and with the reduction in the
amount of subchondral bone.Conclusions: This study characterized changes in the structure of epi-
physeal bone, subchondral bone plate and epiphyseal trabecular bone
together with degenerative changes in articular cartilage and synovium,
and knee joint discomfort and pain in four rat OA models. The amount
of bone decreased in the rat OA models exhibiting from mild to mod-
erate degenerative changes in articular cartilage, whereas the amount
of bone remained unchanged or increased in the rat OA models
exhibiting from moderate to severe degenerative cartilage changes.
These results can be used to design studies for testing the preclinical
treatment effects of OA drug candidates on articular cartilage, syno-
vium, epiphyseal bone, and knee joint discomfort and pain.
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COMMON GENES BETWEEN HUMAN AND RODENT OSTEOARTHRITIS
CARTILAGE STUDIES SHOW LITTLE OVERLAP WITH AN
INFLAMMATORY GENE-SET
A. Chanalaris. Univ. of Oxford, Oxford, United Kingdom
Purpose: We were interested to compare published gene sets of
microarray studies on cartilage samples from rodent models of surgi-
cally induced, chemically induced and spontaneous osteoarthritis (OA).
We also compare the datasets to published gene sets from human
osteoarthritic cartilage, in order to determine genes that are dysregu-
lated in osteoarthritis regardless of species and models used.
Furthermore wewere interested to identify which of those genes might
be related with infammation.
Methods: We used gene sets that adhered to the following criteria:
1) Was from pure cartilage or from samples enriched for cartilage
2) The species of origin was mouse, rat or human
3) We only preferred studies that have been deposited in a public
database
4) We compared the datasets to a gene-set that was bioinformatically
constructed to consider genes that are involved on the onset, resolution
and response to inﬂammation. The study was gene centric, rather than
probe centric and the genes mapping to the probes for each microarray
was used for annotation purposes. For comparison of the different
species, all genes were converted to the mouse ENTREZ gene ids. The
common data sets were examined for gene ontology term enrichment
and KEGG pathway enrichment.
Results: A high degree of overlap between the surgically and chemically
induced OA models in rodents was observed. KEGG pathway analysis
reveals that TGF beta pathway is the only pathway that is not over-
represented in the chemically induced array.
In total we identify 75 genes that are common in more than 50% of the
arrays. In this group of 75 genes only 7 appear to be present in the
inﬂammatory gene-set (p>0.05). However, if single arrays are examined
the probability mass function of the overlap with the inﬂammatory
gene-set is always less than 0.05 and for some arrays as low as 6.2 x 10-
14. At the 4 weeks time point the probability mass function increased.
10 genes are present in more than 8 out of the 11 OA datasets studied
with no inﬂammatory counterpart.
Conclusions: The cartilage response that leads to OA appears to follow a
common transcriptional trajectory regardless of the insult that has
caused it. Although inﬂammatory molecules produced by the cartilage
are part of the OA response, a signiﬁcant part of the transcriptional
cartilage response appears to be independent to inﬂammation.
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MCP-1-CCR2 LIGAND-RECEPTOR AXIS IN HUMAN CHONDROCYTE
DEGRADATION AND DISEASE PROGRESS IN OSTEOARTHRITIS
X. Yuankun, Sr.. Peking Univ., Beijing, China
Purpose: To investigate the role of (OA).
Methods: Expression of the C-C chemokines monocyte chemo-
attractant protein 1 (MCP-1), and it's receptor CCR-2, was assessed in 16
OA patients and 6 normal controls, by reverse transcriptase-polymerase
chain reaction (RT-PCR), enzyme-linked immunosorbent assay (ELISA)
on MCP-1 stimulated chondrocytes, and the apoptosis of the chon-
drocytes was detected by ﬂow cytometry. While, the Expression of the
markers, collagen I, V, IX, XI and Matrix metalloproteinases (MMP), of
chondrocyte degenerationwas assessed by ELISA. Finally, as to estimate
the essentiality of MCP-1-CCR2 ligand-receptor axis in induce and
maintain the pathologic features of OA, the CCR-2 antagonist
(RS102895) was used to block the animal model of OA in rats induced by
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A320intra-articular injection of monoiodoacetate (MIA), and the joint
degeneration was assessed with the OARSI cartilage degeneration score
in histological assessments of the joints of the rats.
Results: The MCP-1 itself enhanced the autocrine of MCP-1 in OA and
normal human cartilage and the Expression of collagen I, V, IX, XI and
Matrix metalloproteinases (MMP) increased after Stimulation of MCP-1.
The MCP-1 also induced the apoptosis of normal and OA chondrocytes.
The CCR-2 antagonist retarded the establishment of a monoiodoacetate
(MIA)-induced animal model of OA in rats.
Conclusions: The results of this study prove that the MCP-1-CCR2
ligand-receptor axis plays an important role in the progress of the OA's
pathology. Inhibition of the MCP-1-CCR2 ligand-receptor axis may
retard the pathological progress of human OA. And, we speculate that
lots of OA patients that etiology is unclear can gain some cues from the
MCP-1-CCR2 ligand-receptor axis, according to our present study.
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BONE GEOMETRY OF THE HIP IS ASSOCIATED WITH OBESITY AND
EARLY STRUCTURAL DAMAGE e A 3.0T MRI STUDY OF
COMMUNITY-BASED ADULTS
A. Teichtahl y, Y. Wang z, S. Smith z, A. Wluka z, M. Zhu z, D. Urquhart z,
G. Giles x, R. O'Sullivan z, F. Cicuttini z. yBaker IDI/Monash Univ.,
Melbourne, Australia; zMonash Univ., Melbourne, Australia; xCancer
Council Victoria, Melbourne, Australia
Purpose: The mechanism by which obesity increases the risk of hip
osteoarthritis (OA) is unclear. One mechanism may be by mediating
abnormalities in bony geometry, which may in turn be associated with
early structural abnormalities, such as cartilage defects and bone mar-
row lesions (BMLs).
Methods: 141 older adults with no diagnosed hip OA had weight and
body mass index (BMI) measured between 1990 and 1994 and again in
2009-10. Acetabular depth and lateral centre edge angle (LCEA), both
measures of acetabular over-coverage, as well as femoral head cartilage
volume, cartilage defects and BMLs were assessed with 3.0T MRI per-
formed in 2009-10.
Results: Current BMI, weight and weight gain were associated with
increased acetabular depth and LCEA (all p  0.01). For every one mil-
limetre increase in acetabular depth, femoral head cartilage volume
reduced by 59mm3 (95% CI 98mm3 to 20mm3, p < 0.01). Greater ace-
tabular depth was associated with an increased risk of cartilage defects
(OR 1.22, 95% CI 1.03e1.44, p ¼ 0.02) and BMLs (OR 1.29, 95% CI
1.01e1.64, p ¼ 0.04) in the central region of the femoral head. LCEAwas
not associated with hip structure.
Conclusions: Obesity is associated with acetabular over-coverage.
Increased acetabular depth, but not the LCEA, is associated with
reduced femoral head cartilage volume and an increased risk of carti-
lage defects and BMLs. Minimising any deepening of the acetabulum,
for example through weight management, might help to reduce the
incidence of hip OA.
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THE BENEFICIAL ROLE OF PAI-1 IN BONE-CARTILAGE INTERACTION
M.F. Pustjens y, S.C. Mastbergen y, W.H. Noort-Van der Laan z,y,
R.J. Van Heerwaarden z, F.P. Lafeber y. yUniv. Med. Ctr. Utrecht, Utrecht,
Netherlands; z St. Maartenskliniek, Woerden, Netherlands
Purpose: In osteoarthritis (OA) subchondral bone changes are seen in
addition to cartilage changes. In treatments targeted at bone, such as
treatment with strontium ranelate (Reginster, 2013), or treatments with
bone involvement such as osteotomy (Jung et al, 2014) or joint dis-
traction (Intema et al, 2012) cartilage repair has been demonstrated.
These studies support the hypothesis that a reset of bone can lead to
cartilage repair. However, the exact biochemical interactions and how
this contributes to repair and degradation processes is less well known.
Plasminogen activator inhibitor (PAI)-1, inhibits plasmin which
accounts for higher levels of MMPs in OA. It is expressed in subchondral
bone and cartilage. The present study evaluates the role of plasminogen
activator inhibitor 1 (PAI-1) in bone-cartilage interaction and its direct
effects on osteoarthritic cartilage.
Methods: Osteoblast culture supernatant from healthy (n¼14) and OA
(n¼16) donors was tested on both healthy and OA cartilage and pro-
teoglycan (PG) synthesis was studied. Expression levels of mediators
were assessed in the osteoblast culture supernatants by Luminexanalysis. Subsequently, OA cartilage (n¼11 donors) was cultured in
absence/presence of PAI-1 and PG synthesis changes were studied.
Results: PG synthesis of OA cartilage was increased (þ34%, p¼0.036)
upon addition of healthy osteoblast supernatant. Importantly, a
decrease was seen when OA osteoblast supernatant was added to
healthy cartilage (-31% PG synthesis, p¼0.001). PAI-1 was expressed at
signiﬁcant higher levels in healthy osteoblasts compared to OA osteo-
blasts (184ng/ml vs 91ng/ml, resp.p¼0.015). Moreover, osteoblast PAI-1
levels were positively correlated with PG synthesis (r¼0.595, p¼0.042)
inﬂuenced by the osteoblasts. Culturing OA cartilage in direct presence
of PAI-1 (2000ng/ml) revealed 33% (p¼0.026) increase of PG synthesis
conﬁrming the beneﬁcial role of PAI-1 in the osteoblast cultures.
Conclusions: Healthy osteoblast derivedmediators lead to PG synthesis
increase in OA cartilage, while it has no effect on healthy cartilage.
Moreover, OA osteoblast derived mediators lead to a decrease in PG
synthesis in healthy cartilage, but not in OA cartilage. Higher PAI-1
levels in these osteoblasts cultures are clearly correlated with higher PG
synthesis in cartilage, which hints at a role for PAI-1 in cartilage repair.
Its direct effects on OA cartilage, increasing PG synthesis, further con-
ﬁrmed the relevance of PAI-1. This supports that targeting bone directly
or involvement of bone might be feasible as treatment for OA.
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INVOLVEMENT OF TGFß1 IN THE INITIAL PHASE OF TMJ AND KNEE
OSTEOARTHRITIS
E.M. Long, R.E. Seegmiller, P. Reynolds. Brigham Young Univ., Provo, UT,
USA
Purpose: The objective of this study was to elucidate OA progression in
an animal model of Stickler syndrome by assessing the expression of an
identiﬁed inﬂammatory marker associated with OA, viz., TGFß1. The
study provides potential mechanistic insight into disease progression
based on the temporal expression of TGFß1 in knee and tempor-
omandibular joints (TMJ).
Methods: The study involved mice carrying the autosomal semi-
dominant disproportionate micromelia (Dmm/þ) mutation in the C-
propeptide coding region of the Col2a1 gene. Speciﬁcally, six wild type
control (þ/þ) and six heterozygous (Dmm/þ) mice were evaluated for
each joint. The mice were euthanized at three, six, and nine months of
age, and their TMJs and knee joints were isolated, ﬁxed, decalciﬁed,
embedded in parafﬁn, and sectioned at 6mm thickness. Three months of
age coincides with the initial detection of histopathology in several
murine models of OA. To determine OA status, selected tissues were
stained with Safranin O to identify proteoglycans and counterstained
with Fast Green. The extent of staining and onset of OA were quantiﬁed
using Modiﬁed Mankin and OARSI scoring systems. Selected tissue
sections of each genotypewere also stained immunohistochemically for
the presence of TGFß1, the inﬂammatory mediator that has been
identiﬁed to play a role in OA progression.
Results: The results revealed Mankin and OARSI scores consistent with
OA-like changes. These changeswere detectable as early as threemonths
in Dmm/þ mice when compared with normal joint biology observed in
control animals. Compared to basal expression in control TMJs and knee
joints, staining for TGFß1 demonstrated augmented expression in Dmm/
þmice as early as threemonths of age, with overexpression persisting in
six-month-old mutant mice, but then disappearing at nine months of
age. The present study demonstrated that TGFß1 was overexpressed in
TMJ and knee articular cartilage of three- and six-month-old Dmm/þ
mice when compared with age-matched controls.
Conclusions: Early TGFb1 expression levels suggested that this
inﬂammatory mediator is involved in the earliest stages of TMJ OA.
Further studies are underway that could shed light on TGFB1 and the
use of other inﬂammatory markers such as HtrA1 and SMADs as pos-
sible targets for therapeutic intervention.
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ACTIVATION OF THE RENIN-ANGIOTENSIN SYSTEM INTRODUCES
OSTEOARTHRITIS
K. Yamagishi, I. Tsukamoto, M. Akagi. Kinki Univ., Osakasayama City,
Osaka, Japan
Purpose: In 2013, we reported that the local renin-angiotensin system
(RAS) can modulate the hypertrophic differentiation of chondrocytes.
